Day: July 23, 2020

WOBURN, Mass., July 23, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2020. The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chronic health conditions.Q2 2020 Highlights:Total revenue of $1.4 million provided a gross margin of $0.9 million, at a gross margin rate of 63.6%. The COVID-19 effects on the economy and health care delivery adversely affected customer orders in all product lines. DPNCheck® contributed $0.8 million revenue with about 46% coming from Asian markets. Quell® contributed $0.4 million revenue and ADVANCE $0.1 million revenue.   Operating expenses were reduced to $1.7 million with lower variable spending in S&M and G&A. The R&D program maintained...

HighlightsRecord net sales for Q2 2020 with both overall and base business sales growth of 14%Q2 2020 diluted EPS increase of 20% to a record $3.87 or an increase of 23% to $3.72, excluding tax benefits in both periodsRecord cash provided by operations of $221.2 million, an increase of $123.8 million from the first half of 20192020 earnings guidance increased to $6.90 – $7.30 per diluted share or $7.05 – $7.45, excluding non-cash impairments recorded in Q1 2020, from previous $5.30 – $5.90 range or $5.45 – $6.05, excluding impairmentsCOVINGTON, La., July 23, 2020 (GLOBE NEWSWIRE) — Pool Corporation (Nasdaq/GSM:POOL) today reported record results for the second quarter of 2020.“The second quarter of 2020 presented a unique opportunity for our business as families continued to search for safe, at-home leisure...

OLNEY, Md., July 23, 2020 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc., (Nasdaq-SASR), the parent company of Sandy Spring Bank, today reported a $14.3 million net loss ($0.31 per share) for the second quarter of 2020.  The loss was the result of the combination of merger and acquisition expense, the impact of the current economic forecast in the determination of the allowance for credit losses and the additional provision for credit losses associated with the acquisition of Revere Bank (“Revere”), which closed on April 1, 2020.   The 2020 second quarter’s result compares to net income of $28.3 million ($0.79 per diluted share) for the second quarter of 2019 and $10.0 million ($0.28 per diluted share) for the first quarter of 2020. Operating earnings for the current quarter, which exclude the impact of merger and acquisition expense,...

Upcoming GEN-009 data update planned for July 30th at 8 a.m. EDTFiled IND application for GEN-011 and is working with the FDA to provide additional informationPrivate Placement with Leading Life Science Investment FundsConference call today at 8:30 a.m. EDTCAMBRIDGE, Mass., July 23, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today reported its operating and financial results for the second quarter ended June 30, 2020. Genocea had an active and productive second quarter, demonstrating important progress across the Company:GEN-009On July 30, 2020, the Company plans to present initial clinical data on the first 5 patients from Part B with Dr. Maura L. Gillison, MD, PhD, Professor of Medicine, Department of Thoracic/Head and Neck...

FORT WORTH, Texas, July 23, 2020 (GLOBE NEWSWIRE) — American Airlines Group Inc. (NASDAQ: AAL) today reported its second-quarter 2020 financial results, including:Second-quarter pretax loss of $2.7 billion. Excluding net special items1, second-quarter pretax loss of $4.3 billion.Second-quarter net loss of $2.1 billion, or ($4.82) per share. Excluding net special items1, second-quarter net loss of $3.4 billion, or ($7.82) per share.Boosted available liquidity by a net $3.6 billion in the quarter through offerings of common stock, convertible bonds and secured bonds.Ended second quarter with approximately $10.2 billion of available liquidity. Additionally, signed term sheet with the U.S. Department of the Treasury for $4.75 billion secured loan, which is expected to close in the third quarter, and announced two senior secured note...

Revenue$69.1 million for H1 2020$28.8 million for Q2 2020Cash (used in)/provided by operating activities

GREAT NECK, N.Y., July 23, 2020 (GLOBE NEWSWIRE) — Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) announced today that its total revenues for the three months ended June 30, 2020 were approximately $1,741,000 compared to approximately $1,779,000 for the three months ended June 30, 2019, a decrease of $38,000, or 2.1%. The decrease in revenues was primarily attributable to lower interest rates and origination points charged on loans due to market conditions and intense competition from other lenders, as well as lower demand for new loans resulting from the COVID-19 pandemic. For the three months ended June 30, 2020 and 2019, approximately $1,490,000 and $1,487,000, respectively, of our revenues were attributable to interest income on secured commercial loans that we offer to small businesses, and approximately $251,000 and $292,000,...